MedTrace Logo

Physical Activity and Fatigue in Early Multiple Sclerosis (MS)

NCT00882453 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1739

Last updated 2012-05-30

No results posted yet for this study

Summary

The purpose of this observational study is to obtain a survey on physical activity in patients who for the first time have experienced symptoms which indicate a high risk for developing multiple sclerosis (MS) and in patients with recently diagnosed MS, and to obtain information on factors potentially influencing the patients' level of activity.

Conditions

Interventions

DRUG

Interferon beta-1b (Betaseron, BAY86-5046)

Intravenous therapy according to product information

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Australia
  • Austria
  • Bahrain
  • Belgium
  • Canada
  • Colombia
  • Czechia
  • Denmark
  • Egypt
  • France
  • Germany
  • Greece
  • Indonesia
  • Israel
  • Italy
  • Jordan
  • Kazakhstan
  • Kuwait
  • Lebanon
  • Mexico
  • Netherlands
  • Norway
  • Oman
  • Portugal
  • Slovenia
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • United Arab Emirates
  • United Kingdom

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00882453 on ClinicalTrials.gov